Nature Clinical Practice Oncology

Title Publication Date Language Citations
DNA methylation and gene silencing in cancer2005/12/01English748
Lessons from phase III clinical trials on anti-VEGF therapy for cancer2006/01/01English742
Do stress-related psychosocial factors contribute to cancer incidence and survival?2008/05/20English623
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer2006/05/01English583
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies2008/08/12English506
Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy2006/08/01English457
REporting recommendations for tumor MARKer prognostic studies (REMARK)2005/08/01English346
Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer2005/06/01English323
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress2007/02/01English313
The concurrent chemoradiation paradigm—general principles2007/02/01English299
Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy2008/02/26English271
Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma2008/11/18English243
Metastasis: a therapeutic target for cancer2008/02/05English238
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?2006/12/01English236
Drug Insight: histone deacetylase inhibitors—development of the new targeted anticancer agent suberoylanilide hydroxamic acid2005/03/01English228
Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself2005/03/01English213
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer2005/01/01English211
Mechanisms of Disease: inflammation and the origins of cancer2005/02/01English197
Strategies for the management of hepatocellular carcinoma2007/07/01English186
Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer2007/10/01English181
Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?2008/03/18English180
The chemoradiation paradigm in head and neck cancer2007/03/01English166
Management of nonmelanoma skin cancer in 20072007/08/01English158
Human papillomavirus in cervical and head-and-neck cancer2008/01/01English155
Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial2006/10/01English154
Response criteria for glioma2008/08/19English146
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures2007/12/01English144
Angiogenic inhibitors: a new therapeutic strategy in oncology2005/11/01English142
The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens2006/08/01English141
Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification2007/05/01English138